| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $0 | — | — |
| Cost of Revenue | $0 | — | — |
| Gross Profit | $0 | — | — |
| R&D Expense | $122K | — | -86.3% |
| SG&A Expense | $814K | — | -57.3% |
| Operating Income | -$1.2M | — | +61.3% |
| Interest Expense | $227K | — | +11.1% |
| Pre-tax Income | -$300K | — | +90.0% |
| Income Tax | -$63K | — | — |
| Net Income | -$237K | — | +92.1% |
| EPS (Basic) | $0.00 | — | +100.0% |
| EPS (Diluted) | $0.00 | — | +100.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Current Assets | $45.3M | +84.1% | — |
| Total Assets | $93.6M | +0.8% | — |
| Current Liabilities | $696K | -50.8% | — |
| Total Liabilities | $20.4M | +5.3% | — |
| Stockholders' Equity | $73.2M | -0.3% | +5788.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $74K | — | +105.3% |
| Capital Expenditures | $1.9M | — | — |
| Investing Cash Flow | -$1.9M | — | — |
| Financing Cash Flow | $1.8M | — | +26.3% |
| Free Cash Flow | -$1.8M | — | -29.7% |